Surgery clinical trials at UCSF
4 in progress, 3 open to eligible people
Surgery helps treat health problems by fixing or removing parts of the body. UCSF is testing therapy for older adults undergoing major surgeries. One study looks at a new way to care for eyes after cataract surgery. Another trial compares different anesthesia types to see which helps patients recover more quickly.
BRSR: Feasibility and Acceptability Pilot
open to eligible people ages 65 years and up
The goal of this clinical trial is to test problem solving therapy (PST) in older adults who are undergoing major surgery. The main question it aims to answer is: • What is the feasibility and acceptability of delivering PST to older surgical patients with depressive symptoms or report lacking social support in the pre-operative and post-operative setting?
San Francisco, California
Dropless Postoperative Regimen After Cataract Surgery in a Vulnerable, County-hospital Population
open to eligible people ages 18 years and up
The current postoperative cataract surgery eye drop regimen used at Zuckerberg San Francisco General Hospital (ZSFG) is a significant burden for its patient population, contributing to high rates of non-adherence and the development of postoperative complications. The investigators propose to replace this complex regimen with a single administration of intraocular antibiotic and subconjunctival steroid at the time of surgery. This pilot study will obtain the preliminary data required to eventually fully evaluate this innovation in postoperative care in a safety-net population with respect to postoperative outcomes, patient compliance, and patient and caregiver satisfaction.
San Francisco, California
Trajectories of Recovery After Intravenous Propofol Versus Inhaled VolatilE Anesthesia Trial
open to eligible people ages 18 years and up
The investigators will conduct a 12,500-patient randomized multi-center trial to determine (i) which general anesthesia technique yields superior patient recovery experiences in any of three surgical categories ((a) major inpatient surgery, (b) minor inpatient surgery, (c) outpatient surgery) and (ii) whether TIVA confers no more than a small (0.2 %) increased risk of intraoperative awareness than INVA in patients undergoing both outpatient and inpatient surgeries
San Francisco, California and other locations
Insignia™ Hip Stem Outcomes Study
Sorry, in progress, not accepting new patients
The objective of this study is to evaluate the safety and effectiveness of the Insignia™ Hip Stem for global market access and post-market clinical follow-up up to 10 years postoperative.
San Francisco, California and other locations
Our lead scientists for Surgery research studies include Sriranjani Padmanabhan Jeremy Juang, MD Victoria Tang, MD, MAS Matthieu Legrand, MD.
Last updated: